ArticleCell chemical biology2022

In vivo drug discovery for increasing incretin-expressing cells identifies DYRK inhibitors that reinforce the enteroendocrine system.

Lianhe Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.